Chronic Musculoskeletal Pain
Conditions
Keywords
Education, Chronic pain, Musculoskeletal pain, Self-efficacy
Brief summary
Chronic musculoskeletal pain (CMP) is highly prevalent, disabling and with high socio-economic costs, with many negative effects on quality of life. CMP affects the ability to perform work, social, recreational and domestic tasks by changing the mood and concentration of this population that suffers. In a study carried out in 2010, 17% of the Spanish population had experienced pain in the last month and according to the severity of symptoms 12% felt severe , 64% moderate and 24% mild pain. In this same study it is specified that 61% was due to back pain, 29% due to neck pain and 23% due to shoulder pain. Pain neuroscience education (PNE) has been shown as an effective treatment strategy in increasing knowledge and understanding of neurobiology, neurophysiology and pain processing, modifying beliefs about it, improving patient skills and encouraging to the accomplishment of physical and social activities in different chronic pathologies.
Detailed description
Study design and setting: The design of the present study will be a quasi-experimental study with 2 follow-ups (one month and four months after intervention) that will be performed between Apr 2018 and Apr 2020 in public health system in Malaga, Spain. The outcomes will be assessed at baseline (t0), one month (t1) and four months after the physiotherapy treatment begins (t2). Written informed consent will be acquired for all participants prior to their participation.
Interventions
BEHAVIORALPNE+Physiotherapy
Physiotherapy cover kinesitherapy and exercises techniques. Besides that it will be covered the understanding and acknowledgement about how pain is processed.
PROCEDUREPhysiotherapy
Physiotherapy cover kinesitherapy and exercises techniques.
Sponsors
Fundación Pública Andaluza Progreso y Salud
University of Malaga
Study design
Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No
Inclusion criteria
* Age between 18-65 years * Chronic Musculoskeletal Pain according to the ACCTION-APS Pain Taxonomy (AAPT), included chronic axial musculoskeletal low back pain
Exclusion criteria
* Chronic postoperative musculoskeletal pain and chronic musculoskeletal pain related to a traumatic injury six months before the beginning of the trial * Inability to provide written informed consent and/or complete questionnaires in Spanish.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline self-efficacy at 1 and 4 months | 1 and 4 months | This outcome will be measured with the Chronic Pain Self-Efficacy Scale |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline pain and pain interference at 1 and 4 months | 1 and 4 months | This outcome will be measured with the Graded Chronic Pain Scale |
| Change from Baseline analgesic medication at 1 and 4 months | 1 and 4 months | This outcome will be measured checking digital medical history |
Other
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline pain knowledge at 1 and 4 months | 1 and 4 months | This outcome will be measured with the revised Neurophysiology of Pain Questionnaire |
Countries
Spain
Outcome results
None listed